1,554
Views
11
CrossRef citations to date
0
Altmetric
Commentary

Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , & ORCID Icon show all
Pages 1694-1703 | Received 23 Sep 2021, Accepted 13 Dec 2021, Published online: 07 Jan 2022

References

  • Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, et al. 2010. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem. 29(3):730–741.
  • Becker RA, Ankley GT, Edwards SW, Kennedy SW, Linkov I, Meek B, Sachana M, Segner H, Van Der Burg B, Villeneuve DL, et al. 2015. Increasing scientific confidence in adverse outcome pathways: application of tailored Bradford-Hill considerations for evaluating weight of evidence. Regul Toxicol Pharmacol. 72(3):514–537.
  • Bernier MO, Baysson H, Pearce MS, Moissonnier M, Cardis E, Hauptmann M, Struelens L, Dabin J, Johansen C, Journy N, et al. 2019. Cohort profile: the EPI-CT study: a European pooled epidemiological study to quantify the risk of radiation-induced cancer from paediatric CT. Int J Epidemiol. 48(2):379–381g.
  • Beyer J, Petersen K, Song Y, Ruus A, Grung M, Bakke T, Tollefsen KE. 2014. Environmental risk assessment of combined effects in aquatic ecotoxicology: a discussion paper. Mar Environ Res. 96:81–91.
  • Boice JD. Jr 2017. The linear nonthreshold (LNT) model as used in radiation protection: an NCRP update. Int J Radiat Biol. 93(10):1079–1092.
  • Boice JD, Jr, Ellis ED, Golden AP, Girardi DJ, Cohen SS, Chen H, Mumma MT, Shore RE, Leggett RW. 2018. The past informs the future: an overview of the million worker study and the mallinckrodt chemical works cohort. Health Phys. 114(4):381–385.
  • Chauhan V, Said Z, Daka J, Sadi B, Bijlani D, Marchetti F, Beaton D, Gaw A, Li C, Burtt J, et al. 2019. Is there a role for the adverse outcome pathway framework to support radiation protection? Int J Radiat Biol. 95(2):225–232.
  • Chauhan V, Stricklin D, Cool D. 2021a. The integration of the adverse outcome pathway framework to radiation risk assessment. Int J Radiat Biol. 97(1):60–67.
  • Chauhan V, Villeneuve D, Cool D. 2021b. Collaborative efforts are needed among the scientific community to advance the adverse outcome pathway concept in areas of radiation risk assessment. Int J Radiat Biol. 97(6):815–823.
  • Chauhan V, Sherman S, Said Z, Yauk CL, Stainforth R. 2021c. A case example of a radiation-relevant adverse outcome pathway to lung cancer. Int J Radiat Biol. 97(1):68–84.
  • Chauhan V, Wilkins RC, Beaton D, Sachana M, Delrue N, Yauk C, O'Brien J, Marchetti F, Halappanavar S, Boyd M, et al. 2021d. Bringing together scientific disciplines for collaborative undertakings: a vision for advancing the adverse outcome pathway framework. Int J Radiat Biol. 97(4):431–441.
  • Chauhan V, Hamada N, Monceau V, Ebrahimian T, Adam N, Wilkins RC, Sebastian S, Patel ZS, Huff JL, Simonetto C, et al. 2021e. Expert consultation is vital for adverse outcome pathway development: a case example of cardiovascular effects of ionizing radiation. Int J Radiat Biol. 97(11):1516–1525.
  • Conolly RB, Ankley GT, Cheng W, Mayo ML, Miller DH, Perkins EJ, Villeneuve DL, Watanabe KH. 2017. Quantitative adverse outcome pathways and their application to predictive toxicology. Environ Sci Technol. 51(8):4661–4672.
  • Gomes T, Song Y, Brede DA, Xie L, Gutzkow KB, Salbu B, Tollefsen KE. 2018. Gamma radiation induces dose-dependent oxidative stress and transcriptional alterations in the freshwater crustacean Daphnia magna. Sci Total Environ. 628-629:206–216.
  • Grant EJ, Brenner A, Sugiyama H, Sakata R, Sadakane A, Utada M, Cahoon EK, Milder CM, Soda M, Cullings HM, et al. 2017. Solid cancer incidence among the life span study of atomic bomb survivors: 1958–2009. Radiat Res. 187(5):513–537.
  • Hamada N, Fujimichi Y. 2014. Classification of radiation effects for dose limitation purposes: history, current situation and future prospects. J Radiat Res. 55(4):629–640.
  • Helm JS, Rudel RA. 2020. Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast. Arch Toxicol. 94(5):1511–1549.
  • Hauptmann M, Daniels RD, Cardis E, Cullings H, Kendall G, Laurier D, Linet M, Little M, Lubin JH, Preston D, et al. 2020. Epidemiological studies of low-dose ionizing radiation and cancer: summary bias assessment and meta-analysis. J Natl Cancer Inst Monogr. 2020(56):188–200.
  • ICRP. 2007. The 2007 recommendations of the international commission on radiological protection. ICRP Publication 103. Ann ICRP. 37 (2–4):3.
  • ICRP. 2012. ICRP statement on tissue reactions/early and late effects of radiation in normal tissues and organs – threshold doses for tissue reactions in a radiation protection context. ICRP Publication 118. Ann. ICRP. 41(1/2):1.
  • Kaiser JC, Blettner M, Stathopoulos GT. 2020a. Biologically based models of cancer risk in radiation research. Int J Radiat Biol. Jul. 97(1):2–10.
  • Kaiser JC, Misumi M, Furukawa K. 2020b. Biologically-based modeling of radiation risk and biomarker prevalence for papillary thyroid cancer in Japanese a-bomb survivors 1958–2005. Int J Radiat Biol. Jul. 97(1):19–12.
  • Knapen D, Angrish MM, Fortin MC, Katsiadaki I, Leonard M, Margiotta-Casaluci L, Munn S, O'Brien JM, Pollesch N, Smith LC, et al. 2018. Adverse outcome pathway networks I: development and applications. Environ Toxicol Chem. 37(6):1723–1733.
  • LaLone CA, Ankley GT, Belanger SE, Embry MR, Hodges G, Knapen D, Munn S, Perkins EJ, Rudd MA, Villeneuve DL, et al. 2017. Advancing the adverse outcome pathway framework-An international horizon scanning approach. Environ Toxicol Chem. 36(6):1411–1421.
  • Laurier D, Richardson DB, Cardis E, Daniels RD, Gillies M, O’Hagan J, Hamra GB, Haylock R, Leuraud K, Moissonnier M, et al. 2017. The International Nuclear Workers Study (Inworks): a collaborative epidemiological study to improve knowledge about health effects of protracted low-dose exposure. Radiat Prot Dosimetry. 173(1–3):21–25.
  • Little MP, Wakeford R, Borrego D, French B, Zablotska LB, Adams MJ, Allodji R, de Vathaire F, Lee C, Brenner AV, et al. 2017. Leukaemia and myeloid malignancy among people exposed to low doses (<100 mSv) of ionising radiation during childhood: a pooled analysis of nine historical cohort studies. Lancet Haematol. 5(8):e346–e358.
  • Lubin JH, Adams MJ, Shore R, Holmberg E, Schneider AB, Hawkins MM, Robison LL, Inskip PD, Lundell M, Johansson R, Kleinerman RA, et al. 2017. Thyroid cancer following childhood low-dose radiation exposure: a pooled analysis of nine cohorts. J Clin Endocrinol Metab. 102(7):2575–2583.
  • Moe SJ, Wolf R, Xie L, Landis WG, Kotamäki N, Tollefsen KE. 2021. Quantification of an adverse outcome pathway network by Bayesian regression and bayesian network modeling. Integr Environ Assess Manag. 17(1):147–164.
  • NCRP. 2020. Approaches for Integrating Information from Radiation Biology and Epidemiology to Enhance Low-Dose Health Risk Assessment, NCRP Report No. 186, National Council on Radiation Protection and Measurements, 2020.
  • NCRP. 2018. Implications of Recent Epidemiologic Studies for the Linear-Non threshold Model and Radiation Protection, NCRP Commentary 27, National Council on Radiation Protection and Measurements, 2018.
  • NCRP. 2015. Health effects of low doses of radiation: perspectives on integrating radiation biology and epidemiology, NCRP Commentary No. 24, National Council on Radiation Protection and Measurements, 2015.
  • National Research Council. 2007. Toxicity testing in the 21st Century: a vision and a strategy. Washington, DC: The National Academies Press. https://doi.org/10.1080/2F10937404.2010.483176.
  • OECD. 2016a. Guidance document for the use of adverse outcome pathways in developing Integrated Approaches to Testing and Assessment (IATA). Series on Testing and Assessment, No. 260, ENV/JM/MONO. 67, OECD Environment, Health and Safety Publications 2016, Organisation for Economic Co-operation and Development, Paris, France. https://doi.org/10.1787/44bb06c1-en
  • OECD. 2016b. Users’ Handbook supplement to the Guidance Document for developing and assessing Adverse Outcome Pathways. Environment, Health and Safety Publications, Series on Testing and Assessment No. 233, Organisation for Economic Co-operation and Development, Paris, France; [accessed 2016 Oct 25]. http://aopkb.org/common/AOP_Handbook.pdf.
  • Parish ST, Aschner M, Casey W, Corvaro M, Embry MR, Fitzpatrick S, Kidd D, Kleinstreuer NC, Lima BS, Settivari RS, et al. 2020. An evaluation framework for new approach methodologies (NAMs) for human health safety assessment. Regul Toxicol Pharmacol. 112:104592.
  • Pittman ME, Edwards SW, Ives C, Mortensen HM. 2018. AOP-DB: a database resource for the exploration of adverse outcome pathways through integrated association networks. Toxicol Appl Pharmacol. 343:71–83.
  • Pollesch NL, Villeneuve DL, O’Brien JM. 2019. Extracting and Benchmarking Emerging Adverse Outcome Pathway Knowledge. Toxicol Sci. 168(2):349–364.
  • Preston RJ, Rühm W, Azzam EI, Boice JD, Bouffler S, Held KD, Little MP, Shore RE, Shuryak I, Weil MM. 2021. Adverse outcome pathways, key events, and radiation risk assessment. Int J Radiat Biol. 97(6):804–814.
  • Richardson DB, Cardis E, Daniels RD, Gillies M, O'Hagan JA, Hamra GB, Haylock R, Laurier D, Leuraud K, Moissonnier M, et al. 2015. Risk of cancer from occupational exposure to ionising radiation: retrospective cohort study of workers in France, the United Kingdom, and the United States (INWORKS). BMJ. 351:h5359.
  • Salbu B, Teien HC, Lind OC, Tollefsen KE. 2019. Why is the multiple stressor concept of relevance to radioecology? Int J Radiat Biol. 95(7):1015–1024. PMID: 30971149.
  • Schmid S, Song Y, Tollefsen KE. 2021. Inhibition of chitin synthase 1 leading to increased mortality in arthropods. Environ Toxicol Chem. 2021:58.
  • Song Y, Xie L, Lee YK, Tollefsen KE. 2020a. De novo development of a Quantitative Adverse Outcome Pathway (qAOP) Network for Ultraviolet B (UVB) radiation using targeted laboratory tests and automated data mining. Environ Sci Technol. 54 (20):13147–13156.
  • Song Y, Xie L, Lee Y, Brede DA, Lyne F, Kassaye Y, Thaulow J, Caldwell G, Salbu B, Tollefsen KE. 2020b. Integrative assessment of low-dose gamma radiation effects on Daphnia magna reproduction: toxicity pathway assembly and AOP development. Sci Total Environ. 705:135912.
  • Stainforth R, Schuemann J, McNamara AL, Wilkins RC, Chauhan V. 2021. Challenges in the quantification approach to a radiation relevant adverse outcome pathway for lung cancer. Int J Radiat Biol. 97(1):85–101.
  • Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, et al. 2014. Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol Sci. 142(2):312–320.
  • Wang Z, Walker GW, Muir DCG, Nagatani-Yoshida K. 2020. Toward a global understanding of chemical pollution: a first comprehensive analysis of national and regional chemical inventories. Environ Sci Technol. 54(5):2575–2584.
  • Xie L, Solhaug KA, Brede DA, Lind OC, Song Y, Salbu B, Tollefsen KE. 2019. Modes of action and adverse effects of gamma radiation in an aquatic macrophyte Lemna minor. Sci Total Environ. 680:23–34.
  • Xie L, Solhaug KA, Song Y, Johnsen B, Olsen JE, Tollefsen KE. 2020. Effects of artificial ultraviolet B radiation on the macrophyte Lemna minor: a conceptual study for toxicity pathway characterization. Planta. 252(5):86.